UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

Value in health, 2022-01, Vol.25 (1), p.S27-S27

2022

Volltextzugriff (PDF)

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

Annals of internal medicine, 2004-05, Vol.140 (10), p.786

2004

Volltextzugriff (PDF)

Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis

Clinical infectious diseases, 2005-11, Vol.41 (9), p.1316-1323

2005

Volltextzugriff (PDF)

Vigorous HIV-1-Specific CD4$^+$ T Cell Responses Associated with Control of Viremia

Science (American Association for the Advancement of Science), 1997-11, Vol.278 (5342), p.1447-1450

1997

Volltextzugriff (PDF)

Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies

The Journal of infectious diseases, 2005-05, Vol.191 (9), p.1435-1441

2005

Volltextzugriff (PDF)

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection

The Journal of experimental medicine, 2001-01, Vol.193 (2), p.169-180

2001

Volltextzugriff (PDF)

Routine human immunodeficiency virus testing: An economic evaluation of current guidelines

The American journal of medicine, 2005-03, Vol.118 (3), p.292-300

2005

Volltextzugriff (PDF)

Predictive Value of Polymerase Chain Reaction of Cerebrospinal Fluid for Detection of Epstein-Barr Virus to Establish the Diagnosis of HIV-Related Primary Central Nervous System Lymphoma

Clinical infectious diseases, 2004-06, Vol.38 (11), p.1629-1632

2004

Volltextzugriff (PDF)

Tolerability and safety of HIV protease inhibitors in adults

Journal of acquired immune deficiency syndromes (1999), 2004-09, Vol.37 (1), p.1111-1124

2004

Volltextzugriff (PDF)

Prediction of Coronary Heart Disease Risk in HIV-Infected Patients with Fat Redistribution

Clinical infectious diseases, 2003-04, Vol.36 (7), p.909-916

2003

Volltextzugriff (PDF)

Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients

The Journal of infectious diseases, 2002-03, Vol.185 (5), p.599-607

2002

Volltextzugriff (PDF)

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

The American journal of medicine, 2003-12, Vol.115 (8), p.632-641

2003

Volltextzugriff (PDF)

Isolated Antibody to Hepatitis B Core Antigen in Human Immunodeficiency Virus Type-1—Infected Individuals

Clinical infectious diseases, 2003-06, Vol.36 (12), p.1602-1605

2003

Volltextzugriff (PDF)

Strategies for management and treatment of dyslipidemia in HIV/AIDS

AIDS care, 2006-02, Vol.18 (2), p.149-157

Sax, P. E.

2006

Volltextzugriff (PDF)

Longitudinal Analysis of Clinical Markers following Antiretroviral Therapy Initiated during Acute or Early HIV Type 1 Infection

Clinical infectious diseases, 2006-04, Vol.42 (7), p.1024-1031

2006

Volltextzugriff (PDF)

Quantifying the risks and benefits of efavirenz use in HIV‐infected women of childbearing age in the USA

HIV medicine, 2011-02, Vol.12 (2), p.97-108

2011

Volltextzugriff (PDF)

Retroviral Rebound Syndrome with Fatal Outcome after Discontinuation of Antiretroviral Therapy

Clinical infectious diseases, 2005-11, Vol.41 (9), p.e83-e85, Article e83

2005

Volltextzugriff (PDF)

Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease

Journal of acquired immune deficiency syndromes (1999), 2005-05, Vol.39 (1), p.69-77

2005

Volltextzugriff (PDF)

The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection

HIV medicine, 2008-05, Vol.9 (5), p.285-293

2008

Volltextzugriff (PDF)

Recurrence of Mycobacterium avium Infection in Patients Receiving Highly Active Antiretroviral Therapy and Antimycobacterial Agents

Clinical infectious diseases, 2000-03, Vol.30 (3), p.511-514

2000

Volltextzugriff (PDF)

Beyond efficacy: the impact of combination antiretroviral therapy on quality of life

AIDS patient care and STDs, 2005-09, Vol.19 (9), p.563-576

2005

Volltextzugriff (PDF)

The long‐term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model‐based approach

HIV medicine, 2007-10, Vol.8 (7), p.439-450

2007

Volltextzugriff (PDF)

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US

Journal of the International AIDS Society, 2010-11, Vol.13 (S4), p.O3-O3

2010

Volltextzugriff (PDF)

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the United States

HIV medicine, 2011-02, Vol.12 (2), p.97-108

2011

Volltextzugriff (PDF)

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA: Efavirenz use in women

HIV medicine, 2011-02, Vol.12 (2), p.97-108

2011

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(63)

Sprache

Englisch
(62)
Rumänisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(58)
Science & Technology
(57)
Life Sciences & Biomedicine
(55)
Biological And Medical Sciences
(41)
Medical Sciences
(40)
Adult
(37)
Male
(37)
Female
(35)
Infectious Diseases
(31)
Immunology
(24)
Middle Aged
(22)
Hiv
(21)
Hiv Infections - Drug Therapy
(21)
Human Immunodeficiency Virus
(20)
Human Viral Diseases
(18)
Microbiology
(18)
Viral Diseases
(18)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(18)
Psychiatry
(17)
Aids/hiv
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

POSB12 Association Between Remdesivir Treatment and In-Hospital All-Cause Mortality Among Patients Hospitalized with COVID-19

Metabolic effects of rosiglitazone in HIV lipodystrophy: a randomized, controlled trial

Should Resistance Testing Be Performed for Treatment-Naive HIV-Infected Patients? A Cost-Effectiveness Analysis

Vigorous HIV-1-Specific CD4$^+$ T Cell Responses Associated with Control of Viremia

Response to Hepatitis B Vaccine in HIV-1–Positive Subjects Who Test Positive for Isolated Antibody to Hepatitis B Core Antigen: Implications for Hepatitis B Vaccine Strategies

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection

Routine human immunodeficiency virus testing: An economic evaluation of current guidelines

Predictive Value of Polymerase Chain Reaction of Cerebrospinal Fluid for Detection of Epstein-Barr Virus to Establish the Diagnosis of HIV-Related Primary Central Nervous System Lymphoma

Tolerability and safety of HIV protease inhibitors in adults

Prediction of Coronary Heart Disease Risk in HIV-Infected Patients with Fat Redistribution

Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse-Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Protease Inhibitor-Experienced Patients

Projecting the cost-effectiveness of adherence interventions in persons with human immunodeficiency virus infection

Isolated Antibody to Hepatitis B Core Antigen in Human Immunodeficiency Virus Type-1—Infected Individuals

Strategies for management and treatment of dyslipidemia in HIV/AIDS

Longitudinal Analysis of Clinical Markers following Antiretroviral Therapy Initiated during Acute or Early HIV Type 1 Infection

Quantifying the risks and benefits of efavirenz use in HIV‐infected women of childbearing age in the USA

Retroviral Rebound Syndrome with Fatal Outcome after Discontinuation of Antiretroviral Therapy

Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease

The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection

Recurrence of Mycobacterium avium Infection in Patients Receiving Highly Active Antiretroviral Therapy and Antimycobacterial Agents

Beyond efficacy: the impact of combination antiretroviral therapy on quality of life

The long‐term benefits of genotypic resistance testing in patients with extensive prior antiretroviral therapy: a model‐based approach

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the United States

Quantifying the risks and benefits of efavirenz use in HIV-infected women of childbearing age in the USA: Efavirenz use in women

Suchergebnisse filtern